Let me know Senator Alexander when you will be holding a hearing for family members to testify how their loved ones were prescribed dangerous opioids, became addicted and died because of criminal marketing by pharma.
Marianne Skolek Perez, Investigative Reporter
(MYRTLE BEACH) On February 12, the National Director of Policy and Advocacy for the U.S. Pain Foundation testified at a hearing of the U.S. Senate Committee on Health, Education, Labor, and Pensions. The hearing “Managing Pain During the Opioid Crisis” was chaired by U.S. Senator Alexander. The National Director arrived on the Senate floor laying on a cot and at the point of testimony, transferred to sitting in a chair. In 2015, she had testified in front of the U.S. Senate laying on a yoga mat holding a microphone.
In this week’s testimony, the National Director said chronic pain and opioid use disorder are distinct and separate diseases. No Senator Alexander, chronic pain is not a disease — it is a symptom of a physical or psychological problem that needs to be properly diagnosed by a physician. Opioid use disorder is just that — it is a disorder — not a disease. Unfortunately too many physicians prescribe dangerous and highly addictive opioids for chronic pain as a result of aggressive marketing by pharmaceutical companies who finance organizations such as the U.S. Pain Foundation. That is why this country is experiencing an opioid epidemic of unprecedented proportions.
Since you gave time to the U.S. Pain Foundation to promote their agenda, will you be holding hearings for families whose loved ones were prescribed opioids, became hopelessly addicted and died? These families deserve to be heard.
Many are not aware of the history of the U.S. Pain Foundation which was founded in 2011 by a chronic pain patient. This past year, the Connecticut Attorney General’s office began an investigation into financial discrepancies and embezzlement by the founder of the U.S. Pain Foundation. The amount of embezzlement was approximately $2 million — and the founder was asked “to resign.” The Foundation has also had problems with keeping their registration current and paying taxes.
Former U.S. Senator Claire McCaskill of Missouri had conducted an investigation into opioid makers and came away with some interesting facts. Between 2012 and 2017, pharmaceutical companies, including Purdue Pharma, maker of OxyContin and Insys Therapeutics, maker of Subsys (Fentanyl) funded organizations to the tune of approximately $9 million. One of the organizations benefiting from the windfall was the U.S. Pain Foundation in an effort to shape the policy and public opinion concerning opioids. Guidelines were issued minimizing the risks of opioid addiction, lobbying to change laws aimed at curbing opioid abuse, promoting opioids for chronic pain and seeking to protect physicians sued for over-prescribing painkillers, according to the report.
Senator Alexander and his committee members might want to take the time to view the video link below. There is a trial going on now in Boston — Insys Therapeutics, maker of Subsys (Fentanyl) and their CEO’s accused of aggressively promoting Subsys for chronic pain resulting in death. It had been approved by the FDA for treatment of pain in cancer patients. This video minimizes and makes a mockery of the dangers of opioids.
https://www.google.com/amp/s/www.bostonglobe.com/business/2019/02/13/rap-video-opioid-salesmen-boasted-their-prowess/YsPTTbiDYDq1ZIpEtobmXL/amp.html
Let me know Senator Alexander when you will be holding a hearing for family members to testify how their loved ones were prescribed dangerous opioids, became addicted and died because of the criminal marketing by pharma. My guess is the families will not need to place any props on the Senate floor to gain your attention.
Marianne Skolek Perez
Consultant to attorneys on opioid lawsuits filed throughout the country
Investigative Reporter covering the opioid epidemic writing for
Global News Centre, Salem-News.com, Sons of Liberty Media, The Washington Standard and Freedom Outpost
908-285-1232 - cell
Global News Centre’s Marianne Skolek, is an Investigative Reporter who focuses on the Prescription Opioid/Heroin Epidemic in the U.S. and Canada. In particular, Marianne has covered the criminal marketing of OxyContin going back to 1999 and continuing to the present.
In 2002, Marianne lost her daughter, Jill to prescribed OxyContin which her physician referred to as “mobility in a bottle.” It was, in fact, death in a bottle. After doing extensive research on the maker of OxyContin, Purdue Pharma, Marianne began working with the Department of Justice in Virginia in their criminal investigation into Purdue Pharma and in July 2007 was asked by the U.S. Attorney John Brownlee prosecuting the case to testify against the three CEO’s of Purdue Pharma, Michael Friedman, Paul Goldenheim, MD and Howard Udell, Chief Counsel. The CEO’s pleaded guilty to misleading the medical profession about the dangers of OxyContin. Marianne also testified against Purdue Pharma at a Judiciary Hearing of the U.S. Senate in July 2007.
In addition, a dangerous and highly addictive opioid named Zohydro has been approved by the FDA against their Advisory Committee’s advice and Marianne continues to alert Attorneys General, Senators and Congressmen as to the FDA’s irresponsibility in the out of control prescription opioid/heroin epidemic killing and addicting in the tens of thousands each year. Zohydro has been referred to as “heroin in a capsule” and its lowest dosage (10mg) contains twice as much hydrocodone as found in a Vicodin pill. The highest single dose of Zohydro contains as much hydrocodone as 5 to 10 tablets of Vicodin or Lortab. Zohydro mixed with alcohol can be fatal and has no abuse deterrent built in which will make it easy to crush and deliver a fatal dose of the opioid.
Currently Marianne has been instrumental in calling for the termination of Margaret Hamburg, MD, Commissioner of the FDA as well as Bob A. Rappaport, MD and Douglas Throckmorton, MD for their lack of commitment to safeguarding the American public against the prescription opioid/heroin epidemic. Marianne’s research, writing and contact with government agencies and attorneys has also exposed the heavily funded pain foundations set up by the pharmaceutical industry and their paid physician spokespersons who convinced the medical boards in 50 states and Canada that dangerous opioids such as OxyContin were less likely to be addictive. These physicians — in particular Scott Fishman, MD, J. David Haddox, DDS, MD, Perry Fine, MD, Lynn R. Webster, MD, Russell Portenoy, MD also downplayed the risks of addictive opioids in books as authors. These books are still available for sale and promoted to the medical profession.
Here are links to Marianne’s involvement in exposing the national conspiracy of the prescription opioid/heroin epidemic, the FDA, the pharmaceutical industry, their pain foundations and paid physician spokespersons.
http://www.salem-news.com/by_author.php?reporter=Marianne%20Skolek
http://www.youtube.com/watch?v=tmPG1VjD61U&list=UUWoHUEr4ZAbQOfIqtOArjgg&index=6&feature=plcp
https://www.facebook.com/photo.php?v=855537227796352&set=vb.658186307531446&type=2&theater